Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Aimovig Global Growth in USD by Year
Aimovig Global Growth in USD (% USD) (%)
Novartis Aimovig Global Growth in USD: 7.0% in FY2025, down 10.0 pts from a year earlier.
Latest, FY2025
7.0%
Period ended Dec 31, 2025
Change on a year earlier
-10.0 pts
17.0% in FY2024
History
5 years
Since FY2020
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| Aimovig | 335 | 312 | 7 | 3”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Aimovig Global Growth in USD (% USD) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.0% | -10.0 pts | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 17.0% | -5.0 pts | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2023 | Dec 31, 2023 | 22.0% | +21.0 pts | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2022 | Dec 31, 2022 | 1.0% | – | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2020 | Dec 31, 2020 | 59.0% | – | Novartis Form 6-K (0001370368-21-000008) ↗ |
Cite this data
StockData. (2026). Novartis Aimovig Global Growth in USD (%), annual FY2020–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-aimovig-yoy-usd-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.